Evidence map›Paper›PMID 23292683›Full record

ArticleNature neuroscience2013

Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl⁻ homeostasis.

Francesco Ferrini, Tuan Trang, Theresa-Alexandra M Mattioli, Sophie Laffray, Thomas Del'Guidice, Louis-Etienne Lorenzo, Annie Castonguay, Nicolas Doyon, Wenbo Zhang, Antoine G Godin and 7 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02992938 (Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia), which is not on this map. Cited by 244 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
244citing papers in PubMed, 1 pooled it
23.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02992938 phase4completednot on this mapstarted 2016, after this paper: background citation

Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia: Randomize Double Blind Clinical Trial

TypeinterventionalSponsorUniversity of ChileRan2016 to 2018Enrolled50ConditionsHyperalgesia, Opioid-Related DisordersArmsAcetazolamide, Placebo Oral Tablet
3 · Its place in the literature

Who cites it

244 citing papers in PubMed, 1 synthesis or guideline pooled it, 428 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

184 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Francesco FerriniInstitut Universitaire en Santé Mentale de Québec, Québec, Canada.
Tuan Trang
Theresa-Alexandra M Mattioli
Sophie Laffray
Thomas Del'Guidice
Louis-Etienne Lorenzo
Annie Castonguay
Nicolas Doyon
Wenbo Zhang
Antoine G Godin
Daniela Mohr
Simon Beggs
Karen Vandal
Jean-Martin Beaulieu
Catherine M Cahill
Michael W Salter
Yves De Koninck
Institut Universitaire en Santé Mentale de Québec · CAUniversity of Toronto · CAQueen's University · CAUniversity of Calgary · CAUniversity of California, Irvine · US

Funding

CIHR 134759-1Howard Hughes Medical Institute
6 · The paper itself

Abstract

A major unresolved issue in treating pain is the paradoxical hyperalgesia produced by the gold-standard analgesic morphine and other opiates. We found that hyperalgesia-inducing treatment with morphine resulted in downregulation of the K(+)-Cl(-) co-transporter KCC2, impairing Cl(-) homeostasis in rat spinal lamina l neurons. Restoring the anion equilibrium potential reversed the morphine-induced hyperalgesia without affecting tolerance. The hyperalgesia was also reversed by ablating spinal microglia. Morphine hyperalgesia, but not tolerance, required μ opioid receptor-dependent expression of P2X4 receptors (P2X4Rs) in microglia and μ-independent gating of the release of brain-derived neurotrophic factor (BDNF) by P2X4Rs. Blocking BDNF-TrkB signaling preserved Cl(-) homeostasis and reversed the hyperalgesia. Gene-targeted mice in which Bdnf was deleted from microglia did not develop hyperalgesia to morphine. However, neither morphine antinociception nor tolerance was affected in these mice. Our findings dissociate morphine-induced hyperalgesia from tolerance and suggest the microglia-to-neuron P2X4-BDNF-KCC2 pathway as a therapeutic target for preventing hyperalgesia without affecting morphine analgesia.

Indexed as

AnimalsBiophysical PhenomenaBrain-Derived Neurotrophic FactorCD11b AntigenChloridesDown-RegulationGene Expression RegulationHomeostasisHot TemperatureHyperalgesiaIon Channel GatingK Cl- CotransportersMaleMembrane PotentialsMiceMice, Inbred C57BLBrain-Derived Neurotrophic FactorCD11b AntigenChloridesK Cl- CotransportersMorphineNaloxoneNarcotic AntagonistsNarcoticsP2rx4 protein, mouseProtein Synthesis InhibitorsReceptors, Purinergic P2X4Ribosome Inactivating Proteins, Type 1SaporinsSymporters

Identifiers

PMID23292683
PMCPMC4974077
OpenAlexW2021440104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.